Haleon (HLN) Depreciation and Depletion (2022 - 2023)
Haleon (HLN) posted Depreciation and Depletion of $121.6 million for Q4 2023, up 26.46% on a QoQ basis from $96.2 million in Q4 2022, and up 26.46% year-over-year from $96.2 million in Q4 2022.
Haleon (HLN) Depreciation and Depletion (2022 - 2023) Analysis & Trends
Haleon's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $121.6 million for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 21.60 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 121.63 Mn |
| Dec 31, 2023 | 121.63 Mn |
| Dec 31, 2022 | 96.18 Mn |
| Dec 31, 2022 | 96.18 Mn |